Jennifer Lund, Ph.D.

Jennifer Lund Ph.D.

Follow Jennifer Lund

faculty member

Jennifer Lund, Ph.D.

Vaccine and Infectious Disease Division, Fred Hutch

Fax: 206.667.7767
Mail Stop: E5-110

Dr. Jennifer Lund is an immunobiologist who studies regulatory T cells, or Tregs, as well as mucosal immunity to infections using both mouse models as well as human tissues. Tregs are specialized white blood cells that help to keep other immune system components from attacking a patient’s healthy tissues, as occurs in autoimmune diseases. However, Tregs also play a role in ramping up a robust immune response to help clear infectious agents or tumor cells from the body. This dual role underscores the importance of Tregs in managing the body’s powerful defenses, tuning the immune system’s response up or down as the situation warrants. Her research explores the role of Tregs in the immune responses to Herpes Simplex virus-2, West Nile virus, HIV and Zika virus infections. She also studies how the body combats infections at mucosal barriers, which separate the body from the external environment. Because the pathogens that cause the majority of infections of public health importance enter the body at these boundaries, better understanding the “first responder” immune events that occur there could help researchers design improved vaccines as well as other prevention and treatment strategies aimed at reducing the global burden of infectious diseases.

Other Appointments & Affiliations

Associate Professor, Global Health
University of Washington

Graduate Faculty, Global Health
University of Washington

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Member, Center for Innate Immunity and Immune Disease
University of Washington


Ph.D., Immunobiology, Yale University, 2006

M.S., Immunobiology, Yale University, 2005

A.B., Biology, Macalester College, 2001

Research Interests

Regulatory T cell modulation of anti-viral immunity

Mucosal immunity

Immunogenetics and virus infection

Immunity to HSV-2, influenza, West Nile virus, HIV and Zika virus

Find A Clinical Trial

Dr. Lund in the News

Immune signatures of severe COVID disease

Science Spotlight - March 15, 2021

Science on the horizon

Hutch News - December 27, 2019

Inflammatory mucosal T cells: harmful or helpful?

Science Spotlight - November 18, 2019

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210